Millendo Therapeutics, Inc. – NASDAQ:MLND

Millendo Therapeutics stock price today

$1.06
-1.21
-53.51%
Financial Health
0
1
2
3
4
5
6
7
8
9

Millendo Therapeutics stock price monthly change

+115.09%
month

Millendo Therapeutics stock price quarterly change

+115.09%
quarter

Millendo Therapeutics stock price yearly change

+115.09%
year

Millendo Therapeutics key metrics

Market Cap
 11.14M
Enterprise value
 N/A
P/E
 -0.03
EV/Sales
 N/A
EV/EBITDA
 1.68
Price/Sales
 N/A
Price/Book
 0.02
PEG ratio
 N/A
EPS
 -30.36
Revenue
 N/A
EBITDA
 -37.09M
Income
 -38.11M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Millendo Therapeutics stock price history

Millendo Therapeutics stock forecast

Millendo Therapeutics financial statements

Profit Margin

Millendo Therapeutics, Inc. (NASDAQ:MLND): Profit margin
Mar 2020 0 -11.99M
Jun 2020 0 -10.67M
Mar 2021 0 -8.38M
Jun 2021 0 -7.05M
MLND income statement history

Debt to Assets

Millendo Therapeutics, Inc. (NASDAQ:MLND): Debt to assets
Mar 2020 68045000 13.40M 19.7%
Jun 2020 57132000 12.18M 21.33%
Mar 2021 31707000 6.07M 19.17%
Jun 2021 75497000 27.38M 36.27%
MLND balance sheet history

Cash Flow

Millendo Therapeutics, Inc. (NASDAQ:MLND): Cash Flow
Mar 2020 -10.16M -26K 5.58M
Jun 2020 -7.86M 0 -76K
Mar 2021 -11.83M 8K 22K
Jun 2021 0 -84K 55.90M
MLND cash flow history

Millendo Therapeutics alternative data

Millendo Therapeutics
Employees

Millendo Therapeutics, Inc. (NASDAQ:MLND): Employee count
Aug 2023 12
Sep 2023 12
Oct 2023 12
Nov 2023 12
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Millendo Therapeutics other data

Millendo Therapeutics
Insider Trading

Millendo Therapeutics, Inc. (NASDAQ:MLND): Insider trades (number of shares)
Period Buy Sel
Aug 2015 300 0
Sep 2015 9100 0
Oct 2015 8250 0
Mar 2016 802122 0
May 2016 255090 0
Jun 2016 850000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
ALDRICH RICHARD director
 Common Stock 425,000 $7 $2,975,000
Purchase
DIPP MICHELLE director, officer.. Common Stock 425,000 $7 $2,975,000
Purchase
ALDRICH RICHARD director
 Common Stock 20,000 $7.86 $157,200
Purchase
DIPP MICHELLE director, officer.. Common Stock 20,000 $7.86 $157,200
Purchase
ALDRICH RICHARD director
 Common Stock 20,000 $7.56 $151,200
Purchase
DIPP MICHELLE director, officer.. Common Stock 20,000 $7.56 $151,200
Purchase
DIPP MICHELLE director, officer.. Common Stock 20,000 $7.56 $151,200
Purchase
ALDRICH RICHARD director
 Common Stock 16,295 $7.06 $115,043
Purchase
DIPP MICHELLE director, officer.. Common Stock 16,295 $7.06 $115,043
Purchase
ALDRICH RICHARD director
 Common Stock 19,800 $6.93 $137,115
MLND insider trading transactions

Millendo Therapeutics
Patents

Patent
Application
Filling date: 20 Sep 2019 Issue date: 13 Aug 2020
MLND patents

Frequently Asked Questions (FAQ)

  • What's the price of Millendo Therapeutics stock today?

    One share of Millendo Therapeutics stock can currently be purchased for approximately $1.06.

  • When is Millendo Therapeutics's next earnings date?

    Unfortunately, Millendo Therapeutics's (MLND) next earnings date is currently unknown.

  • Does Millendo Therapeutics pay dividends?

    No, Millendo Therapeutics does not pay dividends.

  • How much money does Millendo Therapeutics make?

    Millendo Therapeutics has a market capitalization of 11.14M.

  • What is Millendo Therapeutics's stock symbol?

    Millendo Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "MLND".

  • What is Millendo Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Millendo Therapeutics?

    Shares of Millendo Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Millendo Therapeutics have?

    As Jul 2024, Millendo Therapeutics employs 12 workers.

  • When Millendo Therapeutics went public?

    Millendo Therapeutics, Inc. is publicly traded company for more then 12 years since IPO on 4 Oct 2012.

  • What is Millendo Therapeutics's official website?

    The official website for Millendo Therapeutics is millendo.com.

  • Where are Millendo Therapeutics's headquarters?

    Millendo Therapeutics is headquartered at 110 Miller Ave Ste 100, Ann Arbor, MICHIGAN.

  • How can i contact Millendo Therapeutics?

    Millendo Therapeutics's mailing address is 110 Miller Ave Ste 100, Ann Arbor, MICHIGAN and company can be reached via phone at +1 734 845 9000.

Millendo Therapeutics company profile:

Millendo Therapeutics, Inc.

millendo.com
Exchange:

NASDAQ

Full time employees:

12

Industry:

Biotechnology

Sector:

Healthcare

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

+1 734 845 9000
110 Miller Ave Ste 100
Ann Arbor, MICHIGAN 48104

CIK: 0001544227
ISIN: US60040X1037
CUSIP: 60040X103